"We’ve exhausted all avenues": A small biotech may give up on its ultra-rare disease drug over frustration with the FDA.
Comments
(・_・;)
There's nothing here…
"We’ve exhausted all avenues": A small biotech may give up on its ultra-rare disease drug over frustration with the FDA.